David Stroncek
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 13
- CAR-T cell therapy research 12
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Bonnie Yates (6 shared papers)Daniel W. Lee (5 shared papers)Cindy Delbrook (5 shared papers)Constance M. Yuan (5 shared papers)Ling Zhang (4 shared papers)Nirali N. Shah (7 shared papers)Maryalice Stetler‐Stevenson (5 shared papers)Terry J. Fry (5 shared papers)
- Journals
- Blood (7 papers)Transfusion (1 paper)Journal of Virology (1 paper)Investigative Ophthalmology & Visual Science (1 paper)Cytotherapy (1 paper)
- Partner nations
- United StatesMalaysiaBrazil
In The Last Decade
David Stroncek
19 papers receiving 468 citations
Peers
Comparison fields: 5 of 58
- Clinical Biochemistry 79
- Oncology 244
- Immunology 95
- Genetics 107
- Ophthalmology 21
Countries citing papers authored by David Stroncek
This map shows the geographic impact of David Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stroncek more than expected).
Fields of papers citing papers by David Stroncek
This network shows the impact of papers produced by David Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stroncek. The network helps show where David Stroncek may publish in the future.
Co-authors
The 25 scholars most cited alongside David Stroncek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 106 | |
| 2 | 2016 | 98 | |
| 3 | 2014 | 64 | |
| 4 | 2016 | 42 | |
| 5 | 2015 | 41 | |
| 6 | 2004 | 35 | |
| 7 | 2016 | 27 | |
| 8 | 2015 | 22 | |
| 9 | 2014 | 15 | |
| 10 | 2015 | 8 | |
| 11 | 2010 | 4 | |
| 12 | 2021 | 4 | |
| 13 | 2003 | 3 | |
| 14 | 2017 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2019 | 2 | |
| 17 | 2010 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2013 | 1 | |
| 20 | 2025 | 0 |
About David Stroncek
David Stroncek is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Molecular Biology, Hematology and Immunology, having authored 20 papers that have together received 478 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Acute Lymphoblastic Leukemia research (5 papers), Cytomegalovirus and herpesvirus research (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), CRISPR and Genetic Engineering (2 papers), Acute Myeloid Leukemia Research (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Nanowire Synthesis and Applications (1 paper). The work is most often cited by research in Clinical Biochemistry (79 citations), Oncology (244 citations), Immunology (95 citations), Genetics (107 citations) and Ophthalmology (21 citations). David Stroncek has collaborated with scholars based in United States, Malaysia and Brazil. Frequent co-authors include Bonnie Yates, Daniel W. Lee, Cindy Delbrook, Constance M. Yuan, Ling Zhang, Nirali N. Shah, Maryalice Stetler‐Stevenson, Terry J. Fry, Jong‐Baeck Lim and Hye Won Chung. Their work appears in journals such as Blood, Transfusion, Journal of Virology, Investigative Ophthalmology & Visual Science and Cytotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.